Designing a Commercialization Model for Knowledge-based Products Commercialization in Pharmacology industry
Subject Areas :hojat karimi 1 , Dariush Jamshidi 2 , ahmad askari 3
1 - Ph.D. student of business administration, majoring in marketing, Kish International Branch, Islamic Azad University, International Branch, Kish, Iran.
2 -
3 - Assistant Professor, Department of Management, Lamard Branch, Islamic Azad University, Lamard, Iran.
Keywords: Keywords: Commercialization Development, Product, Knowledge-Based, Pharmaceutical Industry of the Country.,
Abstract :
Hojjat Karimi Dariush Jamshidi Ahmad Askari Abstract Background:The model for the development of commercialization of knowledge-based products in the pharmaceutical industry of the country refers to the design of a framework used to transform technologies and knowledge-based products in the pharmaceutical industry into advanced and profitable commercial products. This model includes stages and methods necessary to achieve competitive advantages, strong financial performance, and sustainable growth in domestic and international markets. Objective:The purpose of this research is to design a model for the development of commercialization of knowledge-based products in the pharmaceutical industry of the country. Methodology:To this end, the identification and selection of indicators were carried out using research literature and exploratory interviews, along with a survey of 11 individuals from pharmaceutical companies. Targeted sampling and theoretical sampling were used to reach theoretical saturation. The collected data were then analyzed using thematic analysis, and a paradigmatic model was constructed, which was analyzed using Maxqda20 software. Findings:The findings of the research revealed the identification of factors for designing a model for the development of commercialization of knowledge-based products in the pharmaceutical industry of the country. Conclusion:The design of the model for the development of commercialization of knowledge-based products in the pharmaceutical industry of the country indicates that synergy among research institutions, industry, and the government plays a key role in the success of this process. This model, with an emphasis on strengthening research infrastructure, facilitating legal processes, and providing financial support to knowledge-based companies, can lead to increased competitiveness of domestic pharmaceutical products in global markets.